Like typical college students, Ben Nemtin and his friends, Dave Lingwood, Duncan Penn and Jonnie Penn craved more excitement than what their daily lives offered. Unlike typical college students, the foursome committed to expanding outside of the monotony and to achieving to-dos on their list of “100 things to do before you die”, including everything from riding a bull (#8) to hosting a cooking show (#42) to helping to deliver a baby (#74). Their quest also included helping a stranger with something on their list for every item the group accomplished. Since first venturing out in 2006 as The Buried Life, with a secondhand video camera and a rented RV, Nemtin and friends have inspired and helped people around the world to achieve their own goals.
What started out as a two week journey to see how many items they could check off their list has become a popular TV show (checked #53 off the list), a #1 New York Times bestselling book (took care of #19), and an inspiring movement that encourages individuals to realize their dreams and help others in the process.
A sought after speaker, Nemtin has inspired individuals at universities, businesses and events around the world, including Harvard Law School and various TEDx presentations (#67—make an important speech). Nemtin’s work has earned him honors including Prism Award and Do Something Award nominations.
Along with a sold-out national book tour and appearances on top-rated programs, including the Today show, Nemtin and The Buried Life were invited to the White House in 2015, in acknowledgement of their efforts in helping others.
With lessons learned from achieving his own goals and helping others with theirs, Nemtin delivers perspective that inspires audiences to dream big, accomplish their objectives and identify creative strategies to help others
Dr. Nese Yuksel
Dr. Yuksel is currently a Professor with the Faculty of Pharmacy and Pharmaceutical Sciences at the University of Alberta. Additionally, she holds a cross-appointment with Alberta Health Services and practices in the Menopause Clinics at the Lois Hole Hospital for Women. Her research goals include bridging her interests in women’s health, osteoporosis and practice-based research to develop innovative techniques to enhance patient care. Dr Yuksel is a NAMS Certified Menopause Practitioner (NCMP), a consultant with the Scientific Advisory Council of Osteoporosis Canada, and on the Board of Directors for SIGMA Canadian Menopause Society. She was the CPhA Canadian Pharmacist of the Year in 2016.
Pharmacists are in an ideal position to support women with their reproductive health needs. A wide range of hormonal contraceptive options is now available to suit a woman’s individual needs and preferences. This session will highlight the continuum of reproductive health options now available in Canada. Current trends include the use of highly effective long acting reversible contraception as a first line contraceptive option. Clinical pearls in managing hormonal contraceptives, as well. As practical counseling strategies to promote contraceptive continuation and adherence will be presented. The pharmacist’s expanding role in improving contraceptive access will be discussed.
Teri, a University of Alberta grad, decided in 2010 to combine her love of travel with her interest in teaching. This meant a move to Perth, Western Australia, the most remote capital city in the world. After being a life-long prairie girl, Teri attempted, rather unsuccessfully, to become a beach bum. Those 4 years in Australia opened her eyes to pharmacy practice and education, and how lucky she was to be a pharmacist in Canada. Now back home in Alberta, and happy to be teaching once again at the UofA, Teri brings some international insight to her teaching philosophy, with a love of all things sunny and sandy.
Teri will talk about pharmacy education from the Australian perspective. She will compare and contrast the teaching practices and programs in Canada and Australia. In addition, Teri will discuss the research she has done comparing what these differences and similarities mean to students.
Dr. Joey Ton
Joey Ton obtained his Bachelor of Science in Pharmacy and his Doctor of Pharmacy at the University of Alberta. Currently, he works with Dr. Mike Allan at the University of Alberta Faculty of Medicine & Dentistry. This role focuses on developing and providing continuing education materials for family physicians of Alberta. Some of the projects he has been involved with include the Tools for Practice distributed by the Alberta College of Family Physicians, Best Science Podcast, and an academic detailing program for Alberta. In addition to this position, Joey continues to practice in a community setting on the weekends..
Trials of 2017: Some New, Some True, and Some Poo: Review of some recent research of this past year and speak to whether they should apply to practice or if they should be ignored. Materials were developed by and alongside Dr. Mike Allan (Tools for Practice and BS Podcast) and the PEER group.
Joey’s focus on evidence based medicine will lead to his talk on recent trials where he will focus on some interesting trials of 2017 and speak about the criticisms and take-away points. The big focus is on the practical aspects of the trials and he will make sure that the students come out, only semi-confused.
Kirsten is a clinical pharmacist at the University of Alberta Hospital where she manages medication therapy for ambulatory patients in the Stroke Prevention Clinic. Kirsten also works as a Clinical Practice Leader for Alberta Health Services, where she supports pharmacists and encourages them to optimize the care they provide patients by working to their full scope of practice. She has also served as an instructor and facilitator with the University of Alberta Practice Development’s Anticoagulation, Lab Values modules, and Clinical Decision Making Modules, and lectures at the Faculty of Pharmacy in the undergraduate and Pharm D programs.
Regardless of our area of practice, decisions we make as pharmacists will affect our patients’ future risk of stroke related morbidity. Antithrombotic therapy in secondary stroke prevention has become more complex with debates over “Dual or Single Antiplatelet,” “Antiplatelet or DOAC?” and “DOAC/Warfarin and Antiplatelet?”
Secondary prevention decisions may be affected by new recanalization options and expanded efforts in AF detection.
This session will present current debates in secondary stroke prevention and review the evidence to assist you when making decisions regarding related therapy.
Dr. Samantha Nutt
Samantha Nutt is an award-winning humanitarian, bestselling author and acclaimed public speaker. A medical doctor and the founder of the renowned international humanitarian organizations War Child Canada and War Child USA, Dr. Nutt has worked with children and their families at the frontline of many of the world’s major crises – from Iraq to Afghanistan, Somalia to the Democratic Republic of Congo, and Sierra Leone to Darfur, Sudan. A leading authority on current affairs, war, international aid and foreign policy, Dr Nutt is one of the most intrepid and recognized voices in the humanitarian arena and is amongst the most sought-after public speakers in North America. With a career that has spanned more than two decades and dozens of conflict zones, her international work has benefited hundreds of thousands of war-affected children globally.
Dr. Nutt is a respected authority for many of North America’s leading media outlets. She is a regular foreign affairs panellist on the acclaimed news program, CBC TV NEWS “The National” with Peter Mansbridge. Nutt’s written work has been published by The Globe and Mail, The National Post, Maclean’s Magazine, Reuters, The Ottawa Citizen and The Huffington Post, among many others, and she has appeared in Time Magazine, Chatelaine Magazine , More Magazine and on CTV National News, Global TV News, NBC Nightly News and BBC World News Service, to name just a few. In November 2015, Dr. Nutt spoke at the Ted Talks Live event on Broadway in New York City.
Dr. Nutt was named one of Canada’s 25 Transformational Canadians by The Globe and Mail, and has been recognized as a Young Global Leader by the World Economic Forum. Time Magazine has featured her as one of Canada’s Five Leading Activists. In July 2011, Dr. Nutt was appointed to the Order of Canada, Canada’s highest civilian honour, for her contributions to improving the plight of young people in the world’s worst conflict zones.
Samantha Nutt graduated summa cum laude from McMaster University, earned an M.Sc in Public Health with distinction from the University of London and holds a Fellowship in Community Medicine (FRCPC) from the Royal College of Physicians and Surgeons of Canada. She is further certified by the College of Family Practice and completed a sub specialization in women’s health through the University of Toronto as a Women’s Health Scholar. Dr. Nutt is the recipient of numerous honorary doctorates from universities in Canada and the U.S.A.
Dr. Nutt is a staff physician at Women’s College Hospital in Toronto and is an Assistant Professor of Medicine at the University of Toronto. She is a Senior Fellow at Massey College, University of Toronto and is on the board of the David Suzuki Foundation.
Marni Panas is a Senior Advisor of Diversity and Inclusion, Alberta Health Services with a focus on creating safe, welcoming and inclusive environments for staff, physicians, patients, families and volunteers. She has been invited to share her experiences and expertise in Patient & Family Centred Care, bereavement and inclusive health for LGBTQ patients and their families locally, nationally and internationally. Most recently she provided testimony as a witness to the Canadian Senate in their deliberations on Bill C16 (An Act to amend the Canadian Human Rights Act and Criminal Code). Marni is also a transgender woman who has been very transparent throughout her journey in hopes of fostering acceptance through education and respectful dialogue.
We will explore how to better work with, support and advocate for patients, family, friends and colleagues who identify as sexual or gender diverse (LGBTQ). Participants will hear personal experiences and stories, learn terminology, and discuss what we can do to improve the experience for this often marginalized and vulnerable population.
- Understand the lived and learned realities of sexual and gender minority (LGBTQ) people
- Breaking down the myths and misunderstandings about transgender people
- Skills in creating a safe, supportive and nurturing environment for people of a sexual or gender minority.
- Skills in communicating with and about LGBTQ people in a way that is respectful and meaningful
Dr. Ross Tsuyuki
Dr. Tsuyuki is currently a Professor of Medicine (Cardiology) and Director of the Epidemiology Coordinating and Research (EPICORE) Centre (a health research coordinating centre). He is also an honorary Professor in the School of Pharmacy at the University of Waterloo.
Dr. Tsuyuki has received several awards for teaching and mentorship, as well as appointment as a Fellow of the Canadian Society of Hospital Pharmacists and the American College of Cardiology. In 2005, he was recognized as the Canadian Pharmacist of the Year by the Canadian Pharmacists Association .
His interests include: improving public health through engaging community pharmacists as primary care providers (interventional pharmacy practice research). He is also very involved in the provision of support for other researchers and training the next generation of health researchers.
Pharmacy is about patient care, and with a broader scope of practice, there is more we can do for our patients. Alberta has the broadest scope of practice in the world, and our research group has been conducting pharmacy practice research studies to provide evidence for that advanced scope of practice.
In this presentation, Dr. Tsuyuki will present evidence for pharmacist prescribing and care in the areas of diabetes, hypertension, dyslipidemia and cardiovascular risk reduction. In addition, he will present a compelling economic model for hypertension which shows that pharmacist prescribing is not only better than usual care, but will also save money for our healthcare system (but only if we actually do it!).
Dr. Jaris Swidrovich
Dr. Swidrovich is a member of Yellow Quill First Nation and was born, raised, and continues to reside in Saskatoon, Saskatchewan. He graduated from the University of Saskatchewan in 2010 with a Bachelor of Science in Pharmacy (BSP) and completed a Doctor of Pharmacy (PharmD) from the University of Toronto in 2013.
Both in his previous and current work as a clinical pharmacist, and as a Lecturer at the College of Pharmacy and Nutrition at the University of Saskatchewan, he is dedicated to educating health care workers and students on Indigenous issues and reconciliation. Dr. Swidrovich is involved with “Indigenizing” the University of Saskatchewan in a variety of areas and frequently finds himself working with fellow faculty both locally and nationally on how to proactively address the Truth and Reconciliation Commission of Canada’s Calls to Action.
In his career thus far, he has worked as a Clinical Coordinator of Pharmaceutical Services with the Saskatoon Health Region, where his clinical work included caring for adult inpatients living with HIV/AIDS and substance use disorders. Within this area of expertise, Dr. Swidrovich also works with, and advocates for, not only the Indigenous population, but the diverse (e.g., LGBTQ) and marginalized (e.g., homeless) populations who may be living with HIV/AIDS, mental illness, and poverty. He remains active on the City of Saskatoon’s Cultural Diversity and Race Relations Committee, as a Director on the board of Sanctum Care Group (a transitional care home and hospice in Saskatoon for people living with HIV), and is a regular clinical pharmacist and mentor at SWITCH, which is the Student Wellness Initiative Toward Community Health that operates out of Westside Community Clinic in the core neighbourhood of Saskatoon.
Pharmacists are ideally situated on the front lines of health promotion, disease prevention, and, of course, participating in the treatments of various ailments. In these various roles, we undeniably see a high proportion of Indigenous people, patients, and families. Understanding the concept and enforcement of culturally safe care can help ensure our Indigenous patients receive the best possible care, given some unique differences between Indigenous and non-Indigenous patients.
This session will highlight important aspects of Indigenous history necessary to appreciate current health disparities, examine the current state of health of Indigenous people in Canada, describe culturally safe care with tips on how to engage in providing culturally safe care, and suggest tangible ways to contribute to reconciliation in health care and pharmacy education in Canada.
An overview of terminology and a brief summary of Indigenous history will be provided followed by a deeper discussion on Indigenous Health, cultural safety, and reconciliation. Suggestions will be provided regarding how to encourage, celebrate and coordinate the inclusion of traditional healing practices in the chronic disease management of Indigenous peoples in conjunction with the truth and Reconciliation Commission (TRC) of Canada’s Calls to Action. Commonly described “myths” about Indigenous history, peoples, and services will also be discussed.
At the conclusion of this session, the participant will be able to:
- Describe the unique differences in meaning between Indigenous, Aboriginal, First Nations, Metis and Inuit Peoples.
- Summarize key historical government policies and practices that affected and continued to affect the health of Indigenous Canadians.
- Describe the magnitude of health challenges experienced by Indigenous Canadians (e.g., HIV and Mental Illness)
- Describe cultural safety and give examples of how this may be demonstrated when working with Indigenous peoples.
- Summarize the Truth Reconciliation Commission (TRC) of Canada and propose how pharmacy professionals and the profession of pharmacy may respond to the TRC Calls to Action through chronic disease management.
Ron Pohar graduated from the Faculty of Pharmacy at the University of Alberta in 1995 and began his career as a clinical pharmacist specializing in mental health, geriatrics, and smoking cessation, particularly in those with mental illnesses. Ron has extensive training in tobacco addiction and smoking cessation from the Centre for Addictions and Mental Health, and has been involved with many smoking cessation initiatives including the Tobacco Reduction and Cessation (TRaC) Project as well as efforts to remove the sale of tobacco from pharmacies in Alberta. Ron has developed a number of smoking cessation training programs for health care professionals, including accredited certificate level self-study program for pharmacists (Smoking Cessation: Counsel to Quit) and the CATALYST (Call to Action on Tobacco Addiction: A Model for the Busy Pharmacist) Program, a live program that has trained over 5000 pharmacists across Canada in smoking cessation. In his clinical practice, Ron works with inner city residents and those with mental health issues to assist them in tobacco reduction and cessation.
A founding board member of the Alberta Pharmacists’ Association, Ron’s work in smoking cessation has been recognized with local, provincial and national awards including the Alberta Pharmacy Centennial Award of Distinction and a Faculty of Pharmacy and Pharmaceutical Sciences Distinguished Alumni Award.
Patients with psychiatric disorders have significantly higher tobacco usage rates compared to the Canadian average and suffer a significant health burden as a result. Although smoking cessation interventions have been shown to be effective in this patient population, healthcare professionals may not offer treatment due to misconceptions they may have. This presentation will review the complex relationship between tobacco use and psychiatric disorders. It will outline the different treatment strategies, including combination therapies and nicotine replacement therapies and the rationale for their use. New evidence demonstrating the neuropsychiatric safety of oral therapies for smoking cessation in mental health patients will also be reviewed. The presentation will provide recommendations for difference pharmacotherapeutic options which are safe and effective in this patient population and provide recommendations for management of quit attempts, including an approach to recognizing and managing drug interaction with smoking cessation.
Michael Landsberg has been a prominent face and voice on the Canadian sports scene since 1984. With his unique style, he quickly became one of this country’s most polarizing personalities- perceived by some as forthright and others as arrogant.
In 2009 people began to agree more on Michael after he publicly shared his, then decade long, struggle with severe depression and anxiety. Since then, he has become one of this country’s loudest voices- pushing for all Canadians to see mental illness as a sickness, not a weakness. Michael frequently used his platform as producer and host of Off the Record on TSN to change people’s opinion of mental illness.
Michael has been an official spokesperson for Bell Let’s Talk Day since that initiative was launched. In 2015 Michael launched his own initiative, a not-for-profit, called SickNotWeak. SickNotWeak is dedicated to changing the way Canadians see mental illness. www.SickNotWeak.com gives a voice to celebrities and everyday folks to share their struggles and their views on mental health issues.
In January 2017, Whole Health Pharmacy Partners and SickNotWeak partnered together to provide better support for patients with mental health needs through pharmacies. Through patient focus groups, they were able to launch a patient driven mental health campaign that went way beyond the four walls of the pharmacy.
Michael Landsberg will discuss his journey through mental illness and the impact this has had on his life and others. He will touch on his battle with medications and why pharmacists have the opportunity to play such an important role in the lives of their patients and caregivers with mental health conditions.
Dr. Patrick Mayo
Pat Mayo, is a clinical pharmacist working with the palliative care service at the University of Alberta Hospital. He is a Clinical Associate Professor at the Faculty of Pharmacy and Pharmaceutical Sciences with research interests in the PK-PD of opioid and non-opioid analgesics and the genomics of neuropathic and nociceptive pain. He holds a BSc in pharmacy, a PhD specializing in PKPD relationships, and a Masters in Theological Studies. He is member of the Clinical Ethics Committee for the University of Alberta Hospital and a Second Opinion Reviewer for the Alberta Research Ethics Community Consensus Initiative (ARECCI). Pat works to improve symptom control and seeks to provide clinical options to improve the quality of life in terminally ill patients. Pat has participated in the Canadian Society of Hospital Pharmacists (CSHP), Alberta College of Pharmacists (ACP) and Alberta Health Services (AHS) working groups on medical assistance in dying (MAID). In addition to his work in Palliative Care, Pat has extensive experience in the pharmacotherapy of chronic-cancer pain including the increasingly problematic use of opioids in this patient population.
MAID Presentation Summary:
Canadian legislation was passed in June 2016 that allows dying patients, who are suffering intolerably from a serious medical condition, a choice of a medically-assisted death (MAID). Bill C-14 defines the conditions and limitations for MAID in Canada, which allows physicians and nurse practitioners to provide this service with the assistance of pharmacists. It is essential that all pharmacists understand their role and limitations under the current legislation. Accepted drug protocols and the need for a thorough discussion with the providing practitioner will also be explored. Literature from other jurisdictions providing euthanasia will be reviewed to provide clinical insight into both drug choice and administration route selection. The ethical need to respect patient autonomy will be reviewed along with the individual’s right for objection. Because MAID represents only one option in the continuum of end-of-life care, the continued role of palliative care and meaning of life interventions will also be discussed
Opioid Presentation Summary:
In 2016, there were 2458 apparent opioid-related deaths in Canada resulting in an apparent opioid related death rate in Canada of 8.8 per 100,000 population. This is despite increased awareness of the dangers of prescription opioid use. Concurrently, illicit use of high potency opioids such as fentanyl and carfentanil, have increased the lethality of available street drugs. Prescription and illicit opioid use are linked through a complex set of circumstances that involved an effort to effectively treat chronic non-cancer pain, over-reach by pharmaceutical companies, and 2007/2008 economic crisis. This presentation will provide a summary of this complex narrative so that the participant can understand the circumstances that have led to this health crisis and the harm reduction strategies designed to save lives while working towards comprehensive and effective solutions for chronic pain and addiction.
Cassandra completed her undergraduate degree at the University of Ottawa in Biochemistry before entering the pharmacy program at the University of Alberta. Since graduating in 2016, she has started her Masters in Pharmacy Practice at the University of Alberta, in addition to working as a clinical pharmacist with Pharmacare in Edmonton. This fall Cassandra was granted her Additional Prescribing Authorization, and was also awarded a Queen Elizabeth II Graduate Scholarship. Her project focuses on the gap in the literature regarding the prescribing competence and confidence of pharmacists and pharmacy students. There is recent work done in the area of physician and medical student prescribing, however very little with respect to pharmacy. Cassandra is excited to share her journey with all those attending PDW 2018, and cannot wait to open your eyes to the world of a Masters in Pharmacy!
Cassandra plans to discuss what has lead her to embark on a Master’s in Pharmacy Practice, in addition to providing information about which schools offer similar research opportunities. She will also give a glimpse into the life of a graduate student working as a pharmacist, and the many hats she gets to wear. Finally, Cassandra will discuss her research and where she sees it taking her next, once it is complete!
Dr. Deonne Dersch-Mills
Dr. Dersch-Mills is an alumni of the University of Alberta (BScPharm 1999) and Alberta Pharmacy Residency Program (ACPR 2000). Following some years as a clinical pharmacist at the Foothills Medical Centre, she completed her graduate PharmD program at UBC (2007) and returned to Calgary as the Pharmacy Clinical Practice Leader for Pediatrics and Neonatology. In addition to leading research in neonatal and pediatric pharmacology, she has been the Residency Research Advisor for the Calgary and Cancer Zone residency program since 2015. She now more formally supports pharmacists in their research endeavors as the AHS Pharmacy Services Research Coordinator.
Helen Marin was born and raised in Montreal, Quebec where she obtained her Bachelor in Physiology and Masters in Pharmaceutical Sciences at the University of Montreal. She moved to Alberta where she recently completed her Bachelor of Pharmacy at the University of Alberta in 2017.
Having personal experiences with cancer within her own family, Helen wants to make a difference in the lives of patients going through cancer treatment. Hence, she is currently completing her hospital residency in oncology at the Tom Baker and Cross Cancer Center. Throughout her residency, Helen will be completing rotations in internal medicine, hematology, acute care oncology, palliative Care/pain, bone marrow transplant and pediatric oncology. She is also completing a residency research project on de-prescribing in oncology palliative patients.
In addition, she also works part-time as a pharmacist at Shoppers Drug Mart in Beaumont, Alberta. She believes that being actively involved in our communities, promoting healthier lifestyles and assisting others is essential.
Helen will be talking about her experience in oncology as a pharmacy resident. She will be giving a glimpse of what the work day looks like for a hospital pharmacist in oncology. During her presentation, Helen will also be working through oncology cases in order for participants to gain a better understanding of the role pharmacists have in cancer care.
Dr. Rosaleen Boswell
Dr. Boswell is an alumni of the University of Alberta (BSc Pharm 2009) and Alberta Pharmacy Practice Residency Program (ACPR 2010). After 8 years of clinical practice at the University of Alberta Hospital, she recently completed her PharmD for Practicing Pharmacists program at UofA in December 2017. Currently, her practice involves a full time dual clinical role, sharing her time between an inpatient adult cardiology practice and ambulatory care anticoagulation clinic. Other practice areas have included internal medicine, infectious disease, and antimicrobial stewardship.
Dr. Michelle Foisy
Dr. Foisy obtained her Bachelor of Science in Pharmacy at the University of Alberta and Doctor of Pharmacy degree at the State University of New York at Buffalo, and completed a hospital Pharmacy Residency at the Ottawa General Hospital. Michelle was one of the first pharmacists in Canada to establish a specialty practice in HIV care in 1990 and has held positions in academia, hospital and ambulatory practice. She currently works at the Northern Alberta HIV Program in Edmonton. She has presented on and co-authored numerous publications related to HIV, including medication errors, continuity of care, drug interactions, adverse drug reactions, HIV perinatal care and the role of the pharmacist in HIV. In partnership with Alice Tseng (from Toronto) and Pierre Giguere (from Ottawa), they maintain a comprehensive HIV/HCV drug information/interaction website and have recently developed a new application. She a Fellow of the Canadian Society of Hospital Pharmacists and is credentialed as an HIV Specialized Pharmacist through the American Academy of HIV Medicine.
Over the past 3 decades there have been major advances in HIV treatment and we now have over 25 drugs from 6 different classes. In patients who can adhere to therapy and achieve an undetectable viral load, HIV is now considered a chronic manageable disease. Treatment has become more effective, easier to take and is generally less toxic. However, new challenges have emerged as a result of treating an aging population with numerous comorbidities. First-line therapy includes the use of triple combination ARVs with at least two drug classes included in the regimen. ARVs are selected based on efficacy, resistance patterns, tolerability and patient specific factors. To facilitate taking chronic ARVs and to minimize pill burden, the focus in recent years has been on the development of once daily single tablet regimens (STRs) and fixed-dose combination (FDC) formulations. The pros and cons of some of the newer regimens will be highlighted using a case-based format.
Caroline Ibrahim obtained her B. Pharm from Laval University in 2000 and is currently working towards achieving a Master’s in Health Studies degree through Athabasca University. Since graduating in 2000, Caroline has practiced as a pharmacist in both community and hospital settings in Edmonton, Alberta. She is currently working as a Drug Utilization Evaluation (DUE) pharmacist for Alberta Health Services (AHS). As a DUE pharmacist, Caroline is involved in the promotion of rational drug use to improve patient care through evaluation of clinical and economic evidence for drug therapies. In addition, her work involves the development of medication-related policy recommendation and the analysis of usage patterns of medication use within AHS.
Caroline will provide an overview of the formulary system focusing on its value for safe and cost effective pharmacotherapy. She will emphasize how utilization –focused evaluation can be applied to hospital formulary management as well as the importance of outcome evaluation for ongoing drug stewardship. Through this presentation, her goal is to highlight the importance of conducting evaluations that will ultimately be useful to stakeholders. As such, the importance of organizational culture and ethics will be explored.
Dr. Sheri Koshman
Dr. Koshman is currently an Associate Professor of Medicine (Cardiology) at the University of Alberta. She practices in ambulatory cardiology, including the Cardiac EASE clinic and the Heart Function Clinic at the Mazankowski Alberta Heart Institute. She also provides research support as a Research Advisor to pharmacy residents in the Alberta Pharmacy Residency Program. Her clinical practice is full scope and includes; performing full medical histories, physical examination, ordering laboratory tests and independent prescribing. She was one of the first 15 pharmacists to be granted the ability to independently prescribe in Alberta. Her clinical practice has been highlighted in numerous publication as unique and advanced. Her research interests are in cardiovascular pharmacotherapy, including drug utilization and practice patterns, and pharmacy practice, including prescribing and practice roles. In terms of teaching, Dr. Koshman is involved in many levels of teaching including undergraduates (pharmacy, medicine), Doctor of Pharmacy students and residents (pharmacy, medicine). She is also active in continuous professional learning for both pharmacists and physicians.
Dr. Sara Celik
As a Board certified Naturopathic Doctor, Dr. Sara Celik provides an intriguing discussion of health and wellness by addressing topics such as digestive care, cleanses and detoxification. Dr. Celik’s talk will challenge our pharmaceutical frame of mind and encourage listeners to consider how we can aid our patients in improving their wellbeing through appropriate care, healing, and mind-body interconnectivity.